Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
---|
06/09/2010 | EP2194044A1 Quinolone derivative |
06/09/2010 | EP2193788A1 Pharmaceutical compositions comprising colloidal silicon dioxide |
06/09/2010 | EP2193127A1 Benzothiazole compounds |
06/09/2010 | EP1497273B1 Hydroxamic acid derivatives |
06/09/2010 | EP1385864B1 Anti-VEGF-2 antibodies |
06/09/2010 | EP1292308B1 Alpha,beta-unsaturated sulfones for treating proliferative disorders |
06/09/2010 | EP0951295B1 Compositions for use in inhibiting of alpha-v-beta3 mediated angiogenesis |
06/09/2010 | CN1914152B New compounds, methods for their preparation and use thereof |
06/09/2010 | CN1871000B Combinations of potassium channel openers and sodium channel inhibitors or sodium channel-influencing active compounds for treating pain |
06/09/2010 | CN1780835B Novel fused heterocycles and uses thereof |
06/09/2010 | CN101730539A Fibrin gel for controlled release of tgf-beta and uses thereof |
06/09/2010 | CN101724539A Formula of health-care wine and preparation method thereof |
06/09/2010 | CN101724075A Remodeling and glycoconjugation of peptides |
06/09/2010 | CN101724071A Single domain antibodies against TNFRl and methods of use therefor |
06/09/2010 | CN101723997A Puerarin glycosylation derivative, medicine compound, preparation method and application thereof |
06/09/2010 | CN101723948A C-6 modified indazolylpyrrolotriazines |
06/09/2010 | CN101723921A CaSR antagonist |
06/09/2010 | CN101721706A Medicine composition containing matrine class alkaloid, preparation method and pharmaceutical application |
06/09/2010 | CN101721702A Formulation of human antibodies for treating TNF-alpha associated disorders |
06/09/2010 | CN101721701A Crystallization of antibodies or fragments thereof |
06/09/2010 | CN101721676A Gene regulatory peptides |
06/09/2010 | CN101721666A Pharmaceutical composition for treating cervical spondylosis |
06/09/2010 | CN101721662A Bone-strengthening blood-stasis-dissipating plaster |
06/09/2010 | CN101721660A Plaster for curing cervical spondylosis |
06/09/2010 | CN101721651A Traditional Chinese medicine capsule for treating scapulohumeral periarthritis |
06/09/2010 | CN101721631A Hotly-compressed medicine bag for hyperosteogeny |
06/09/2010 | CN101721630A Six-ingredient traditional Chinese medicine preparation for cooling blood and resisting toxicity |
06/09/2010 | CN101721595A Effective method for treating cervical spondylosis |
06/09/2010 | CN101721586A Traditional Chinese medicine external application medicine powder for treating scapulohumeral periarthritis |
06/09/2010 | CN101721580A Bone-knitting Chinese medicament |
06/09/2010 | CN101721579A Medicine for treating fracture |
06/09/2010 | CN101721573A Wet packing agent for treating rheumatoid bone bi-syndrome and preparation method thereof |
06/09/2010 | CN101721568A Pharmaceutical composition for treating rheumatic arthralgia and preparation method thereof |
06/09/2010 | CN101721550A Medicine used after fracture taxis |
06/09/2010 | CN101721537A Traditional Chinese medicine for treating rheumatic and rheumatoid arthritis |
06/09/2010 | CN101721531A Shendeng 4-decoction target field and preparation method thereof |
06/09/2010 | CN101721522A Traditional Chinese medicine medicated wine used for treating cervical spondylosis |
06/09/2010 | CN101721503A Traditional Chinese medicine preparation for treating sterility and infertility of men and women |
06/09/2010 | CN101721499A Medical wine for treating osteoporosis |
06/09/2010 | CN101721497A Traditional Chinese medicine for treating bone hyperplasia |
06/09/2010 | CN101721495A Chinese herbal medicine wine for treating rheumatoid arthritis |
06/09/2010 | CN101721491A Traditional Chinese medicine medical pillow used for treating cervical spondylosis |
06/09/2010 | CN101721484A Traditional Chinese medicine externally-applied agent for treating gonarthromeningitis and preparation method thereof |
06/09/2010 | CN101721483A Traditional Chinese medicine for treating prolapse of lumbar intervertebral disc |
06/09/2010 | CN101721480A Traditional Chinese medicine composition for treating diseases of bone, joint and skin and preparation method thereof |
06/09/2010 | CN101721477A Traditional Chinese medicine for treating spurs |
06/09/2010 | CN101721475A Quality control method for Yaotongning capsules |
06/09/2010 | CN101721468A Method for preparing salvianolic acids |
06/09/2010 | CN101721467A Method for preparing total salvianolic acid |
06/09/2010 | CN101721462A Method for harvesting and primarily processing sianchau |
06/09/2010 | CN101721460A Externally-applied ostealgia-eliminating paste used for treating cervical spondylosis and lumbar vertebra diseases |
06/09/2010 | CN101721454A Traditional Chinese medicine for curing bone tuberculosis |
06/09/2010 | CN101721444A Saussurea involucrate self-micro-emulsion, preparation method thereof and application thereof |
06/09/2010 | CN101721422A Medicine for treating arthritis and preparation method thereof |
06/09/2010 | CN101721402A treating bone-related disorders with selective androgen receptor modulators |
06/09/2010 | CN101720928A Combination for preventing and curing degenerative disease of bone and joint |
06/09/2010 | CN101244213B Externally used Chinese medicinal herb for treating decubitus |
06/09/2010 | CN101219177B Antalgica for neck and waist |
06/09/2010 | CN101204436B Chinese patent medicine for curing hyperosteogeny in knee joint |
06/09/2010 | CN101199723B Chinese medicine compound for oral administration for treating lumbar hyperosteogeny |
06/09/2010 | CN101199721B Chinese medicine pill for treating hip necrosis |
06/09/2010 | CN101194985B Orally taken Chinese medicine composition for treating articulatio genus hyperosteogeny |
06/09/2010 | CN101057880B Traditional Chinese medicine for treating fracture and its preparation method |
06/09/2010 | CN101002838B External application medicine powder for treating hyperosteogeny |
06/08/2010 | US7732622 Naphthalene derivatives |
06/08/2010 | US7732596 2-( beta -D-Glucopyranosyl)-4-(2-phenylethyl)benzo[b]thiophene; prevention or treatment of a disease associated with hyperglycemia such as diabetes, postprandial hyperglycemia, impaired glucose tolerance, diabetic complications or obesity |
06/08/2010 | US7732587 for treatment of TNF-mediated diseases, particularly including chronic inflammatory diseases |
06/08/2010 | US7732459 CCR1 antagonists and methods of use therefor |
06/08/2010 | US7732456 such as 4-benzyloxy-1-{4-[2-(dimethylamino)ethoxy]phenyl}-1H-pyridin-2-one, that as antagonists to melanin concentrating hormone receptors, used for treating cardiovascular, nervous system, metabolic, reproductive system, respiratory system and gatrointestinal disorders |
06/08/2010 | US7732439 Diamino-substituted phenothiazinium compound; antimicrobial photosensitisers effective against Gram negative bacteria, Gram positive bacteria; photodynamic therapy |
06/08/2010 | US7732431 for inducing contraception; for treating menopause; thermoformed packages |
06/08/2010 | US7732146 Method for screening an agent that modulates activity of macrophage migration inhibitory factor |
06/08/2010 | US7731961 Methods of increasing muscle mass or muscle strength using antibody inhibitors of GDF-8 |
06/08/2010 | US7731958 Adjust concentration of interleukins |
06/08/2010 | CA2575902C Treatment and prevention of neoplasms with salts of aminoimidazole carboxamide |
06/08/2010 | CA2439241C Bipiperidinyl-derivatives and their use as chemokine receptors inhibitors |
06/03/2010 | WO2010062829A1 Tryptophan hydroxylase inhibitors for treating osteoporosis |
06/03/2010 | WO2010062399A2 Csf1r extracellular domain fusion molecules and treatments using same |
06/03/2010 | WO2010061971A1 Pyridine-3-carboxyamide derivative |
06/03/2010 | WO2010061903A1 Pyrimidine derivative and pyridine derivative both having pi3k inhibitory activity |
06/03/2010 | WO2010013975A3 A pharmaceutical composition for preventing or treating osteoporosis comprising benzamidine derivative or its salt, and bisphosphonate |
06/03/2010 | WO2010007165A3 Treatment of inflammatory diseases with mammal beta defensins |
06/03/2010 | WO2009121935A3 Pharmaceutical composition with bisphosphonate |
06/03/2010 | US20100137364 6-Aminoisoquinoline Compounds |
06/03/2010 | US20100137338 INHIBITORS OF Akt ACTIVITY |
06/03/2010 | US20100137330 Use |
06/03/2010 | US20100137324 Rho-kinase inhibitors |
06/03/2010 | US20100137319 Pyrrolotriazine compounds useful as kinase inhibitors and methods of treating kinase-associated conditions therewith |
06/03/2010 | US20100137274 Rivaroxaban and derivatives, synthesis; atherosclerosis; arthritis; Alzheimer's disease or cancer |
06/03/2010 | US20100137248 Boron-containing compounds, uses and preparation thereof |
06/03/2010 | US20100137235 Methods for Concomitant Administration of Colchicine and Macrolide Antibiotics |
06/03/2010 | US20100137208 Intratumorally administered lactoferrin in the treatment of malignantneoplasms and other hyperproliferative diseases |
06/03/2010 | US20100137205 Use of FGF-18 Protein, Target Proteins and Their Respective Encoding Nucleotide Sequences to Induce Cartilage Formation |
06/03/2010 | US20100137196 Histone deacetylases, and uses related thereto |
06/03/2010 | US20100137194 Plasminogen Activator Inhibitor-1 Inhibitors and Methods of Use Thereof to Modulate Lipid Metabolism |
06/03/2010 | US20100136575 B7-related nucleic acids and polypeptides useful for immunomodulation |
06/03/2010 | US20100136122 Oral Preparation Comprising Pioglitazone |
06/03/2010 | US20100136120 Compositions and methods for forming and strengthening bone |
06/03/2010 | US20100136118 Calcium absorption enhancer |
06/03/2010 | US20100136086 Dynamic bioactive nanofiber scaffolding |